Literature DB >> 8954127

Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor.

U M Steckelings1, M Artuc, M Paul, M Stoll, B M Henz.   

Abstract

Angiotensin II is a hormone with long known cardiovascular actions. Recent studies revealed an additional role for angiotensin II in the regulation of cell proliferation. This study was performed to clarify whether skin is a target organ for these novel angiotensin actions. Radioligand binding studies identified a high-affinity angiotensin receptor on human primary keratinocytes in vitro with a Kd of 4.5 nM and a Bmax of 0.12 nM. Competition experiments with losartan and PD 123177 revealed that this receptor was not of the AT1- nor the AT2-subtype. Stimulation of human keratinocytes with angiotensin II (10(-10) to 10(-5) M) led to a dose dependent increase in 3H-thymidine incorporation, indicating that the keratinocyte receptor mediates a mitogenic effect. This effect is comparable at 10(-9) M to stimulation of keratinocytes by EGF (50ng/ml) and FGF (50ng/ml). These results demonstrate for the first time a possible physiological role for angiotensin II in human skin involving the regulation of keratinocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954127     DOI: 10.1006/bbrc.1996.1801

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

2.  Angiotensin II stimulates melanogenesis via the protein kinase C pathway.

Authors:  Li-Hong Liu; Xin Fan; Zhi-Kuan Xia; Xu-Xi An; Rong-Ya Yang
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

3.  Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression.

Authors:  H Takeda; S Kondo
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

4.  [Trigger factors for psoriasis].

Authors:  H M Ockenfels
Journal:  Hautarzt       Date:  2003-02-21       Impact factor: 0.751

5.  Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors:  A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal:  Int J Biomed Sci       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.